RxDoctor Payments Data

Christopher Connor, DO

Interventional Pain Medicine · Wilkes Barre, PANPI 1891080024

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $943 of the $1,489 with a category attached, or 63.3%. 7 manufacturers reported payments, led by Boston Scientific at 48.7% of the total. Reporting peaked in 2024 at $779 and has fallen 73.7% since, to $205 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in PA, where the typical reported total is $2,714.

$1,489in general payments, 2019–2025

Across 23 payments — averaging $64.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$726
  • Curonix LLC$564
  • Si-bone, Inc.$116
  • Foundation Fusion Solutions, LLC$32
  • Avanos Medical$20
  • Globus Medical$17
  • plus $15 from 1 others

What the payments were for

  • Travel & lodging$54637%
  • Food & beverage$94363%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,489 in reported general payments places this provider in the 40th percentile of 59 interventional pain medicine providers in Pennsylvania.

See all interventional pain medicine providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$634,537
Medicare patients
1,157
Services billed
30,829

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl12$6,869
Buprenorphine23$6,063
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen142$3,278
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen156$3,140
Gabapentin239$2,935
Pregabalin85$1,617
Oxycodone Hcl86$1,376
Methocarbamol111$1,127
Duloxetine Hcl114$1,102
Diclofenac Sodium38$690
Celecoxib28$637
Morphine Sulfate ErMorphine Sulfate35$569
Tizanidine Hcl52$506
Tramadol Hcl52$352
Baclofen46$339

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Wilkes Barre

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →